Special Issue "Marine Immunomodulators"
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (31 December 2019).
Interests: Glycoconjugates; Lipopolysaccharides; NMR spectroscopy; Innate immunity; NMR study of protein-ligand interaction; NMR-based conformational analysis
About seventy percent of the Earth's surface is covered by water populated by billions of different organisms, yet research into the chemical biology of such marine organisms is limited and mostly unexplored in terms of biology and chemistry beyond. The marine system offers an ecological resource comprising a variety of aquatic plants and animals. Therefore, the marine environment represents countless and diverse resources for new drugs to combat major diseases such as cancer or malaria and a source of molecules that is able to “drive” the mammalian immunity system, i.e., immunodulators. Indeed, the aquatic organisms have to be screened for antibacterial, immunomodulator, anti-fungal, anti-inflammatory, anticancer, antimicrobial, neuroprotective, analgesic, and antimalarial properties. This potential is immense, and these molecules can be used as new drugs for several different purposes.
Marine drugs research is, however, still at a primary stage. Having an enormous variety with a great diversity of organisms and virgin areas of marine life, the prospects of yielding more novel products from the sea is enormous and should be pursued.
The aim of this special issue is to collect as many papers as possible on molecules deriving from marine organisms that have immunomodulatory activity, i.e., are able to modulate innate or adaptative mammalian immune responses. Amplifying such an interesting and astounding area of natural products research has also the secondary aim of getting a clearer idea of the priority of the drugs that are to be developed and possible new drug candidates of a marine origin.
Prof. Alba Silipo
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- marine organisms
- structure-activity relationship
- immunomodulatory molecules
- structural characterization
- NMR spectroscopy
- mass spectrometry